Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma

Clinical Endocrinology

Volumn 79, Issue 6, 2013, Pages 882-886

  Sayki Arslan, Muyesser ^a   Sahin, Mustafa ^b   Topaloglu, Oya ^a   Tutal, Esra ^a   Karakose, Melia ^a   Gungunes, Askin ^a   Cakal, Erman ^a   Ozbek, Mustafa ^a   Delibasi, Tuncay ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROTROPIN; THYROXINE; ANTI-THYROGLOBULIN; AUTOANTIBODY; THYROID MICROSOMAL ANTIBODIES;

ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; CONTROLLED STUDY; FEMALE; HUMAN; HYPERPROLACTINEMIA; MAJOR CLINICAL STUDY; MALE; MICROSOME; PRIORITY JOURNAL; PROLACTINOMA; THYROID FUNCTION; THYROID NODULE; THYROID WEIGHT; BLOOD; CASE CONTROL STUDY; COMPLICATION; HYPOPHYSIS TUMOR; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; THYROID GLAND;

ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERPROLACTINEMIA; MALE; MIDDLE AGED; ORGAN SIZE; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; THYROID GLAND; THYROIDITIS, AUTOIMMUNE; THYROTROPIN; THYROXINE;

EID: 84887451513     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12217     Document Type: Article

References (22)

1. De Bellis, A., Bizzarro, A., Pivonello, R., et al,. (2005) Prolactin and autoimmunity. Pituitary, 8, 25-30. (Pubitemid 44680082)
2. McMurray, R.W., (2001) Estrogen, prolactin, and autoimmunity: actions and interactions. International Immunopharmacology, 1, 995-1008. (Pubitemid 32434420)
3. McLeod, D.S., &, Cooper, D.S., (2012) The incidence and prevalence of thyroid autoimmunity. Endocrine, 42, 252-265.
4. Ferrari, C., Boghen, M., Paracchi, A., et al,. (1983) Thyroid autoimmunity in hyperprolactinaemic disorders. Acta Endocrinologica, 104, 35-41. (Pubitemid 13050046)
5. Kramer, C.K., Tourinho, T.F., de Castro, W.P., et al,. (2005) Association between systemic lupus erythematosus, rheumatoid arthritis, hyperprolactinemia and thyroid autoantibodies. Archives of Medical Research, 36, 54-58. (Pubitemid 40386349)
6. Reber, P.M., (1993) Prolactin and immunomodulation. American Journal of Medicine, 95, 637-644. (Pubitemid 24002383)
7. Ayturk, S., Gursoy, A., Kut, A., et al,. (2009) Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. European Journal of Endocrinology, 161, 599-605.
8. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al,. (1985) Homeostasis Model Assessment: insulin resistance and beta-cell function from fasting blood glucose and insulin concentrations in man. Diabetologia, 28, 412-419. (Pubitemid 15018832)
9. Brunn, J., Block, U., Ruf, G., et al,. (1981) Volumetric analysis of thyroid lobes by real-time ultrasound. Deutsche Medizinische Wochenschrift, 106, 1338-1340. (Pubitemid 11020280)
10. Orbach, H., Zandman-Goddard, G., Amital, H., et al,. (2007) Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Annals of the New York Academy of Sciences, 1109, 385-400. (Pubitemid 47511381)
11. Holdaway, I.M., Evans, M.C., Sheehan, A., et al,. (1984) Low thyroxine levels in some hyperprolactinemic patients due to dopaminergic suppression of thyrotropin. Journal of Clinical Endocrinology and Metabolism, 59, 608-613. (Pubitemid 14012480)
12. Eskildsen, P.C., Kruse, A., &, Kirkegaard, C., (1989) The pituitary-thyroid axis in patients with pituitary disorders. Hormone and Metabolic Research, 21, 387-390. (Pubitemid 19182758)
13. Dieguez, C., Peters, J.R., Page, M.D., et al,. (1986) Thyroid function in patients with hyperprolactinaemia: relationship to dopaminergic inhibition of TSH release. Clinical Endocrinology, 25, 435-440. (Pubitemid 16031781)
14. Ishibashi, M., Kuzuya, N., Sawada, S., et al,. (1991) Anti-thyroid antibodies in patients with hyperprolactinemia. Endocrinologia Japonica, 38, 517-522.
15. Pelkonen, R., Salmi, J., &, Lamberg, B.A., (1982) Interrelationship between TSH- and prolactin secretion in patients with prolactinoma and autoimmune thyroiditis. Acta Endocrinologica, 100, 184-188. (Pubitemid 12115667)
16. Poyraz, B.C., Aksoy, C., &, Balcioǧlu, I., (2008) Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia. European Neuropsychopharmacology, 18, 667-672.
17. Keogh, M.A., &, Wittert, G.A., (2002) Effect of cabergoline on thyroid function in hyperprolactinaemia. Clinical Endocrinology. 57, 699.
18. Knudsen, N., Laurberg, P., Perrild, H., et al,. (2000) Risk factors for goiter and thyroid nodules. Thyroid, 12, 879-888.
19. Yidirim, M., Dane, S., &, Seven, B., (2006) Morphological asymmetry in thyroid lobes and sex and handedness differences in healthy young subjects. International Journal of Neuroscience, 116, 1173-1179. (Pubitemid 44567587)
20. Rapaport, B., Chazenbalk, G.D., Jaume, J.C., et al,. (1998) The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocrine Reviews, 19, 673-716. (Pubitemid 128506520)
21. Rezzonico, J., Rezzonico, M., Pusiol, E., et al,. (2008) Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid, 18, 461-464. (Pubitemid 351519543)
22. Erdoǧan, M.F., Demir, O., Emral, R., et al,. (2009) More than a decade of iodine prophylaxis is needed to eradicate goiter among school age children in a moderately iodine-deficient region. Thyroid, 19, 265-268.